Income Statement
The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.
Paying user area
Try for free
Elevance Health Inc. pages available for free this week:
- Balance Sheet: Liabilities and Stockholders’ Equity
- Common-Size Balance Sheet: Assets
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Enterprise Value to FCFF (EV/FCFF)
- Selected Financial Data since 2005
- Current Ratio since 2005
- Total Asset Turnover since 2005
- Price to Book Value (P/BV) since 2005
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Elevance Health Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Elevance Health Inc., consolidated income statement
US$ in millions
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Revenue Trends
- Premiums exhibited consistent growth from 2020 through 2024, increasing from approximately $104.1 billion to $144.2 billion. Product revenue demonstrated strong upward momentum with a notable acceleration in 2023 and 2024, rising from around $10.4 billion to $22.6 billion over the five-year period. Service fees grew steadily but at a slower pace compared to product revenue, reaching about $8.4 billion by 2024. Overall, operating revenue showed continuous expansion, increasing by nearly 45% from $120.8 billion in 2020 to $175.2 billion in 2024.
- Expense Analysis
- Benefit expense, the largest cost component, increased significantly year over year, from $88.0 billion in 2020 to $127.6 billion in 2024, indicating rising claims or benefit payments. Costs associated with products sold also rose markedly, more than doubling from $8.95 billion in 2020 to $19.75 billion in 2024, reflecting the growth in product revenue. Cost of operating revenue followed a similar upward trend, increasing from $97.0 billion to $147.3 billion within the same timeframe. Operating expenses grew notably between 2020 and 2023, peaking at about $20.1 billion, before plateauing in 2024. Amortization of intangible assets fluctuated but trended downward in 2024.
- Profitability and Operating Performance
- Gross profit showed moderate growth from $23.8 billion in 2020 to a peak of approximately $28.6 billion in 2023, followed by a slight decline in 2024 to $27.9 billion. Operating income increased from $6.0 billion in 2020 to roughly $7.7 billion in 2022 and remained relatively stable thereafter, with a small decrease in 2024 to $7.3 billion. The stability in operating income despite rising revenues and costs suggests effective cost management or margin moderation.
- Investment Activities
- Investment income experienced a steady rise from $915 million in 2020 to $2.1 billion in 2024, reflecting growth in fixed maturity securities and overall investments. Investment expense remained relatively stable and low. Net investment income mirrored the upward trajectory. However, net gains or losses on financial instruments displayed volatility, with positive results in early years turning into losses in 2022 through 2024, which may suggest unfavorable market conditions or investment decisions during those years.
- Other Financial Aspects
- Interest expenses saw a rising trend from $784 million in 2020 to $1.2 billion in 2024, indicating increased borrowing costs or higher debt levels. The gain on sale of business contributed a one-time income boost in 2024 amounting to $201 million. Income before income taxes was relatively stable, ranging from approximately $6.2 billion to $7.9 billion without significant fluctuations. Income tax expense rose in line with pre-tax income, and net income remained roughly constant, fluctuating slightly around $6 billion after peaking in 2021.
- Shareholders' Net Income
- Shareholders' net income closely tracked net income, maintaining a consistent level near $6 billion over the period, suggesting minimal impact from noncontrolling interests and stable earnings attributable to shareholders.
- Summary of Key Insights
- The company demonstrated solid revenue growth primarily driven by premiums and product revenue expansion. Rising benefit expenses and costs affected gross profit margins but were managed to sustain a relatively stable operating income. Investment income was a growing contributor to overall profitability despite some recent investment losses. While interest expenses increased, overall net income and shareholders' earnings showed resilience and stability over the period analyzed.